Champignon Brands Acquires AltMed Capital Corp.

Mantra Pharma Inc. Acquires Cutimed Inc. (Emcure Pharmaceuticals) for up to CAD 5.05 Million

April 2, 2026

Healthcare Services

Emcure Pharmaceuticals’ step-down subsidiary, Mantra Pharma Inc. (Canada), acquired 100% of Cutimed Inc. for up to CAD 5.05 million. Immediately after the acquisition, Cutimed was amalgamated with Mantra effective April 1, 2026 to streamline operations and improve administrative efficiencies, strengthening Emcure’s Canadian cosmetic and dermatological product presence.

Myconic Capital / Ketamine One Acquires Integrated Rehab and Performance Ltd.

April 23, 2021

Healthcare Services

Myconic Capital Corp. (MEDI) entered into a letter of intent to acquire 100% of Integrated Rehab and Performance Ltd. (IRP), a Victoria, British Columbia multidisciplinary physical therapy clinic that specializes in care for veterans, RCMP and first responders. The transaction contemplates payment in MEDI common shares, retention of IRP's CEO, and the introduction of ketamine-assisted therapies and expansion of IRP's clinic network in British Columbia; subsequent press releases indicate Ketamine One signed and closed a definitive agreement to acquire IRP.

KKR Acquires Majority Interest in Therapy Brands

April 7, 2021

Software

KKR has agreed to acquire a majority interest in Therapy Brands, a Birmingham-based practice management and EHR software platform for mental, behavioral and rehabilitation healthcare providers. Existing investor PSG will remain a minority shareholder, and sellers include investment funds affiliated with Lightyear Capital, Oak HC/FT and Greater Sum Ventures; financial terms were not disclosed.

Blackhawk Growth Corp Acquires Trip Pharma Inc.

October 13, 2020

Healthcare Services

Blackhawk Growth Corp. completed the acquisition of all outstanding shares of Trip Pharma Inc., an Edmonton-based psychedelic development and wellness company led by Dr. Krista Leicht. The transaction was satisfied largely with issuance of common shares to Trip Pharma shareholders and brings Trip Pharma into Blackhawk's existing healthcare/cannabis investment portfolio as it pursues clinical research and a psychiatric research clinic focused on psilocybin-based therapies.

Revive Therapeutics Agrees to Acquire Psilocin Pharma Corp.

February 11, 2020

Pharmaceuticals

Revive Therapeutics Ltd. entered into a letter of intent to acquire all issued and outstanding securities of Psilocin Pharma Corp. for an aggregate purchase price of $2.75 million to be satisfied by issuing 55 million common shares of Revive (deemed $0.05/share). Revive deposited 10 million shares ($500,000) into escrow as a deposit; the closing is subject to due diligence and execution of a definitive share exchange agreement.

BR Brands Acquires Mary's Brands (Mary's Medicinals)

August 21, 2019

Consumer Products

BR Brands, a cannabis CPG platform, completed the acquisition of the remaining capitalization and control of Mary's Brands (maker of Mary's Medicinals) concurrent with the first close of BR Brands' Series A, which was backed by strategic capital partner Rose Capital. The deal expands BR Brands' portfolio and manufacturing capabilities as part of a buy-and-build strategy to scale premium cannabis CPG brands across multiple U.S. markets.